Li Yang

Prof. Li Yang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2021 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
LDLili Dong
Lili Dong
YSYang Song
Yang Song
YZYajie Zhang
Yajie Zhang
WZWeikang Zhao
Weikang Zhao
CWChunli Wang
Chunli Wang
LYLi Yang
Li Yang

1 January 2020 in Theranostics
Verified
Journal Article
Open access
LNLucy Wanjiru Njunge
Lucy Wanjiru Njunge
AEAndreanne Poppy Estania
Andreanne Poppy Estania
YGYao Guo
Yao Guo
WLWanqian Liu
Wanqian Liu
LYLi Yang
Li Yang
Over the years, tumor progression locus 2 (TPL2) has been identified as an essential modulator of immune responses that conveys inflammatory signals to downstream effectors, subsequently modulating the generation and function of inflammatory cells. TPL2 is also differentially expressed and activated in several cancers, where it is associated with increased inflammation, malignant transformation, angiogenesis, metastasis, poor prognosis and therapy resistance. However, the relationship between TPL2-driven inflammation, tumorigenesis and tumor immunity has not been addressed. Here, we reconcile the function of TPL2-driven inflammation to oncogenic functions such as inflammation, proliferation, apoptosis resistance, angiogenesis, metastasis, immunosuppression and immune evasion. We also address the controversies reported on TPL2 function in tumor-promoting inflammation and tumorigenesis, and highlight the potential role of the TPL2 adaptor function in regulating the mechanisms leading to pro-tumorigenic inflammation and tumor progression. We discuss the therapeutic implications and limitations of targeting TPL2 for cancer treatment. The ideas presented here provide some new insight into cancer pathophysiology that might contribute to the development of more integrative and specific anti-inflammatory and anti-cancer therapeutics.

21 October 2024 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
YGYan Gao
Yan Gao
SWSixiang Wang
Sixiang Wang
YGYuehong Gao
Yuehong Gao
LYLi Yang
Li Yang